Crystallization Method Development

Crystallization Method Development

We provide comprehensive crystallization method development and optimization services to ensure your active pharmaceutical ingredients (APIs) achieve the desired solid form with high purity, efficiency, and scalability. Leveraging our expertise in solid-state chemistry, we develop robust, reproducible processes that control nucleation, optimize particle size distribution, and enhance critical properties such as dissolution, bioavailability, and manufacturability. Our team systematically fine-tunes process parameters—such as cooling rates, stirring, seeding, and solvent systems—to address challenges like agglomeration, form conversion, and unwanted polymorph formation. With the ability to deliver kilo-scale batches suitable for preclinical development and a strong track record in working collaboratively with API manufacturers, we ensure consistency and predictability across all development stages. From chiral separation to crystallization troubleshooting, we help you streamline production, improve yield, and reduce costs while maintaining the highest quality standards for regulatory compliance.